BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 11391535)

  • 1. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different lobular distributions of altered hepatocyte tight junctions in rat models of intrahepatic and extrahepatic cholestasis.
    Kawaguchi T; Sakisaka S; Sata M; Mori M; Tanikawa K
    Hepatology; 1999 Jan; 29(1):205-16. PubMed ID: 9862868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestasis in a rat model of graft-versus-host disease is accompanied by alteration of the expression and distribution of tight-junction-associated proteins.
    Sasatomi K; Sakisaka S; Kawaguchi T; Hanada S; Taniguchi E; Koga H; Harada M; Sata M
    Int J Mol Med; 2005 Mar; 15(3):431-6. PubMed ID: 15702233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
    Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
    Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study.
    Tsuneyama K; Harada K; Yasoshima M; Kaji K; Gershwin ME; Nakanuma Y
    J Pathol; 1998 Oct; 186(2):126-30. PubMed ID: 9924426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis.
    Kawaguchi T; Sakisaka S; Mitsuyama K; Harada M; Koga H; Taniguchi E; Sasatomi K; Kimura R; Ueno T; Sawada N; Mori M; Sata M
    Hepatology; 2000 Jun; 31(6):1285-95. PubMed ID: 10827154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis.
    Medina JF; Martínez-Ansó ; Vazquez JJ; Prieto J
    Hepatology; 1997 Jan; 25(1):12-7. PubMed ID: 8985258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis.
    Tsuneyama K; Yasoshima M; Harada K; Hiramatsu K; Gershwin ME; Nakanuma Y
    Hepatology; 1998 Sep; 28(3):620-3. PubMed ID: 9731549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
    Sasaki M; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis.
    Harada K; Ozaki S; Gershwin ME; Nakanuma Y
    Hepatology; 1997 Dec; 26(6):1399-405. PubMed ID: 9397977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of biliary intra-epithelial lymphocytes at different anatomical levels of intrahepatic bile ducts under normal and pathological conditions: numbers of CD4+CD28- intra-epithelial lymphocytes are increased in primary biliary cirrhosis.
    Isse K; Harada K; Sato Y; Nakanuma Y
    Pathol Int; 2006 Jan; 56(1):17-24. PubMed ID: 16398675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis.
    Sakisaka S; Koga H; Sasatomi K; Mimura Y; Kawaguchi T; Tanikawa K
    Yale J Biol Med; 1997; 70(4):403-8. PubMed ID: 9626760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
    Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
    Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
    Tsuneyama K; Harada K; Yasoshima M; Hiramatsu K; Mackay CR; Mackay IR; Gershwin ME; Nakanuma Y
    J Pathol; 2001 Jan; 193(1):102-9. PubMed ID: 11169522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ nucleic acid hybridization of pyruvate dehydrogenase complex-E2 in primary biliary cirrhosis: pyruvate dehydrogenase complex-E2 messenger RNA is expressed in hepatocytes but not in biliary epithelium.
    Harada K; Van de Water J; Leung PS; Coppel RL; Nakanuma Y; Gershwin ME
    Hepatology; 1997 Jan; 25(1):27-32. PubMed ID: 8985260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis.
    Harada K; Isse K; Kamihira T; Shimoda S; Nakanuma Y
    Hepatology; 2005 Jun; 41(6):1329-38. PubMed ID: 15880426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Tinmouth J; Lee M; Wanless IR; Tsui FW; Inman R; Heathcote EJ
    Liver; 2002 Jun; 22(3):228-34. PubMed ID: 12100573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant forms of cholestatic diseases involving small bile ducts in adults.
    Kim WR; Ludwig J; Lindor KD
    Am J Gastroenterol; 2000 May; 95(5):1130-8. PubMed ID: 10811317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions.
    Wu CT; Eiserich JP; Ansari AA; Coppel RL; Balasubramanian S; Bowlus CL; Gershwin ME; Van De Water J
    Hepatology; 2003 Oct; 38(4):1018-25. PubMed ID: 14512889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
    Broomé U; Hultcrantz R; Scheynius A
    Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.